Your browser doesn't support javascript.
loading
DNA aneuploidy identifies a subset of Luminal subtype breast carcinoma patients with worse clinical outcome.
Pinto, António E; Matos, João; Pereira, Teresa; Silva, Giovani L; André, Saudade.
Affiliation
  • Pinto AE; Department of Pathology, Portuguese Institute of Oncology of Lisbon, Portugal. Electronic address: aepinto@ipolisboa.min-saude.pt.
  • Matos J; Department of Pathology, Portuguese Institute of Oncology of Lisbon, Portugal.
  • Pereira T; Department of Pathology, Portuguese Institute of Oncology of Lisbon, Portugal.
  • Silva GL; Department of Mathematics, Higher Technical Institute, University of Lisbon, Portugal; Centre for Statistics and Applications, University of Lisbon, Portugal.
  • André S; Department of Pathology, Portuguese Institute of Oncology of Lisbon, Portugal.
Pathol Res Pract ; 246: 154513, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37167811
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Pathol Res Pract Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Pathol Res Pract Year: 2023 Document type: Article